Clinical Trial: Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multicenter Study of the Safety and Efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Patients With Hypophosphatasia (HPP)

Brief Summary: The aim of this study is to assess safety and efficacy of Asfotase Alfa (ALXN1215) in patients with hypophosphatasia